No takes yet. Share an insight, caveat, or question.
Research demonstrates ANKRD1 enhances tumor progression and treatment resistance in lung cancer, suggesting a potential therapeutic target.
Okada et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: